A C Matin, Speaker at Pharma Conferences
Keynote Presentation
A C Matin, Stanford University, United States

The presentation focuses on systemically administered targeted gene therapy using mRNA instead of DNA; why the former is superior for this purpose will be discussed. Lipid nanoparticles (LNPs) and, more recently, extracellular vesicles (EVs, aka exosomes) have proven effective ve [....] » Read More

Howard I Maibach, Speaker at Speaker for Pharma 2023
Keynote Presentation
Howard I Maibach, University of California, United States

In the days before World War 2, Dr. Draize at FDA conceptualized models predictive of potential for skin irritation and allergic contact dermatitis potential that with modifications based on newer experimental data have stood the test of time and remain efficient to today. The in [....] » Read More

Luis Jesus Villarreal Gomez, Speaker at Drug Development
Keynote Presentation
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico

The necessity of new systems for drug delivery in children and specific procedures is clearly needed, in the case of children the difficulty of the correct dose administration is a problem when the drug carrier is not easy to administrate by a non-specialized adult. Mucoadhesive [....] » Read More

Consolato M Sergi, Speaker at Pharma Conferences 2022
Keynote Presentation
Consolato M Sergi, University of Ottawa, Canada

Electronic medical record (EMR)'s use has increased exponentially worldwide. There is a large variety of laboratory information systems (LIS) in the modern healthcare, which may have remarkable advantages over the traditional pen and paper way to record events and data in a p [....] » Read More

Richard Denk, Speaker at Speaker for Pharma 2023
Keynote Presentation
Richard Denk, SKAN AG, Switzerland

The new EU GMP Annex 1 for sterile Manufacturing was published in August 2022. The industry does now have one year time for implementation. Exception loading and unloading for the Lyophilization which provides an implementation time of two years. What does this mean for sterile M [....] » Read More

Stefania Raimondo, Speaker at Speaker for Pharma 2023
Keynote Presentation
Stefania Raimondo, University of Palermo, Italy

Extracellular vesicles (EVs) are lipoproteic particles released by organisms belonging to different kingdoms, and research in recent years has indicated they are mainly involved in cross-kingdom interaction. The content of EVs consists of various biomolecules, such as proteins, n [....] » Read More

Miroslav Radenkovic, Speaker at Speaker for Pharma 2023
Keynote Presentation
Miroslav Radenkovic, University of Belgrade, Serbia

The prevalence of diabetes and obesity is an increasing worldwide problem, and is referred to as the twin epidemics. In the physiological context, today we know that native glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are incretin hormone [....] » Read More

Narapereddy Krishna Prasad, Speaker at Pharmaceutical Conferences
Oral Presentation
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States

A specific HS-GC method has been developed, optimized, and validated for the determination of genotoxic impurity Bromoethane in Vigabatrin (VGB) drug substance. Chromatographic separation of genotoxic Bromoethane impurity was achieved on DB-1 column (30m × 0.53 mm, 5.0 μ [....] » Read More

Merita Kucuku, Speaker at Pharmaceutical Conferences
Oral Presentation
Merita Kucuku, Freelance consultant, Albania

The role of the laboratory is very important for the quality control of medicines, especially for imported medicines. People very often discuss for the efficacy of medicines and this answer can give from the laboratory. Quality control of medicines has an impact on public health [....] » Read More

Saliha Koc Aslan, Speaker at Pharma Conferences
Oral Presentation
Saliha Koc Aslan, Acibadem Healthcare Group, Turkey

Objective: This work aims to examine nurse's medicine implementation Material and Method: This is a retrospective work. 10198 nurses who join the process of medicine implementation in a group hospital between the years of 2017-2020 generates. The number of nurses to be sam [....] » Read More

Kwan Hiu Yee, Speaker at Drug Delivery Conferences
Oral Presentation
Kwan Hiu Yee, Hong Kong Baptist University, China

15,16-dihydrotanshinone I (DHTS) is tanshinones, a class of lipophilic abietane diterpenes rich in Salvia miltiorrhiza Bunge. It has many pharmacological activities. However, the poor solubility and biocompatibility of DHTS have hindered its clinical application. To enhance th [....] » Read More

Eiman Mohammad Shahrour, Speaker at Pharmaceutics Congress
Oral Presentation
Eiman Mohammad Shahrour, Tishreen University, Syrian Arab Republic

Background: Mild osteogenesis imperfecta OI and postmenopausal osteoporosis are both bone disorders. Mild OI may be associated with postmenopausal osteoporosis. According to NCBI, COL1A2rs72658152 (COL1A2G661S) is a pathogenic proven cause of the association between mild OI and p [....] » Read More

Tarek Aboul Fadl, Speaker at Drug Formulation
Oral Presentation
Tarek Aboul Fadl, Assiut University, Egypt

Cellular growth, development, and differentiation are tightly controlled by a conserved biological mechanism: the cell cycle.  Deregulation of the cell cycle is a hallmark of the transformation of normal cells into tumor cells. Given its importance in tumorigenesis, several [....] » Read More

Manuel Narvaez Pelaez, Speaker at Speaker for Pharma 2023
Oral Presentation
Manuel Narvaez Pelaez, University of Malaga, Spain

Dysregulation of hippocampal neurogenesis is linked to several neurodegenereative diseases and depression, where boosting hippocampal neurogenesis in these patients emerges as a potential therapeutic approach. Accumulating evidence for Neuropeptide Y (NPY) and galanin (GAL) inter [....] » Read More

Yue liu, Speaker at Speaker for Pharma 2023
Poster Presentation
Yue liu, Hong Kong Baptist University, China

Nasopharyngeal carcinoma (NPC) is diverse cancer with no well-defined tumor antigen, associated with oncogenic Epstein-Barr Virus (EBV), and with usually late-stage diagnosis and survival <40%. Current radio- and chemotherapy have low effectiveness and cause adverse effects. I [....] » Read More

Bhupendra Gopalbhai Prajapati, Speaker at Pharma Congress 2023
Keynote Presentation
Bhupendra Gopalbhai Prajapati, Shree S.K.Patel College of Pharmaceutical Education and Research, India

Cystic fibrosis is a genetic disease caused by CFTR gene mutations resulting in impaired mucociliary clearance and causing infection, inflammation, and insufficiently working respiratory system. This disease affects more than seventy thousand people across the globe. Multi-organ [....] » Read More

Kpetehoto Hinnoutondji Wilfrid, Speaker at Drug Delivery Conferences
Oral Presentation
Kpetehoto Hinnoutondji Wilfrid, Benin laboratory, Benin

Context and objectives: The treatment of chronic wounds is difficult and expensive. This situation is aggravated by the phenomenon of antibiotic resistance, a public health problem. It is linked to self-medication, non-rational use of conventional antibiotics and empirical use of [....] » Read More

Preeti Sharma, Speaker at Speaker at Pharma 2023
Oral Presentation
Preeti Sharma, Santosh University, India

Background: During covid pandemic period our home restricted life led to many undesirable physical, physiological and mental alterations. Yoga a traditional system of medicines by virtue of its holistic approach towards health and disease and also due to reasonable cost, the [....] » Read More

Jegathambigai R Naidu, Speaker at speaker for Pharma 2023
Oral Presentation
Jegathambigai R Naidu, Manipal University, Malaysia

Recent advances in our understanding of the cellular and molecular events of carcinogenesis have led to the development of a promising therapeutic strategy for the treatment and prevention of cancer. Chemoprevention can be defined as the use of substances of chemical (natural or [....] » Read More

Kalirajan Rajagopal, Speaker at Drug Screening
Oral Presentation
Kalirajan Rajagopal, JSS Academy of Higher Education & Research, India

COVID‐19 has created a major threat to the human population across the globe. Since 2020, there are many mutations in SARS CoV-2 like Alpha, Beta, Delta and Omicron etc.  Out of this Omicron variant is one of the fastest-spreading diseases in Covid-19. But still, we are no [....] » Read More

Jenson Jacob, Speaker at Drug Delivery Conferences
Oral Presentation
Jenson Jacob, Pazhassiraja College, India

Mallotus philippinensis is widely distributed in outer Himalayan regions under the Euphorbiaceae family and are reported to have several pharmacological activities. It has been used as herbal medicine in India and the bark of the plant is used for several disorders like typhoid, [....] » Read More

Ujjwala Y Kandekar, Speaker at Speaker for Pharma 2023
Oral Presentation
Ujjwala Y Kandekar, JSPMs Rajarshi Shahu College of Pharmacy and Research, India

The present study focused on the formulation of mucoadhesive bilayer composite films for the treatment of periodontitis and the evaluation of its physicochemical properties. The primary layer was prepared by flaxseed and HPMC composite to sustain the release of doxycycline hyclat [....] » Read More

Ravi Kumar Kota, Speaker at Drug Delivery Conferences
Oral Presentation
Ravi Kumar Kota, Jawaharlal Technological University, India

Micoballoons of Olmesartan (OLM)were formulated by solvent diffusion method using HPMC, Eudragit and Ethyl Cellulose as rate-controlling polymers. The yield of Micoballoons up to 75.2 - 91.68% and shows good flow properties and on the basis of optical microscopy for prepared Mico [....] » Read More

Bhumika Wadhwa, Speaker at Drug Delivery Conferences
Oral Presentation
Bhumika Wadhwa, MSU, India

Breast cancer metastasis is a serious cause of morbidity and mortality in females globally. Metastatic cells show immune evasion, drug resistance and relapse and frequently differ from the preceding primary breast cancer in properties. Several biological processes, including tumo [....] » Read More

Amit Gupta, Speaker at Pharmaceutical Conferences
Oral Presentation (Virtual)
Amit Gupta, Invertis University, India

Despite the availability of sufficient data on the effects of individual metal exposure on living organisms, a critical knowledge gap still exists in predicting effects of multi-metals particularly on the pituitary-testicular axis. Thus, the aim of the present study was to check [....] » Read More

Lina Abdelrahman Osman Hemmeda , Speaker at Pharmaceutical Conferences
Oral Presentation (Virtual)
Lina Abdelrahman Osman Hemmeda , University of Khartoum, Sudan

Access to free essential medicines is a critical component of universal health coverage. However, the availability of essential medicines in Sudan isn't well studied. As well, the majority of Sudanese people lack health insurance, making out-of-pocket sp ending the primary so [....] » Read More

Ana Isabel Rocha Faustino, Speaker at Pharmaceutical Conferences
Oral Presentation
Ana Isabel Rocha Faustino, University of Evora, Portugal

A carcinogen in any agent able to cause cancer in humans or animals increases cancer incidence or malignancy or shortens the latency period. A chemical is considered carcinogenic after being intensively studied by researchers and after one or more agencies evaluated the evidence [....] » Read More

Peter B Chase, Speaker at Drug Delivery Congress
Oral Presentation
Peter B Chase, Essentia Health- St. Mary's Medical Center, United States

Cannabinoids (phytocannabinoids and synthetic cannabinoids) are most often used during adolescence and given the changing norms, enhanced potency, reduced societal perceptions of risk and multitude of forms of products for consumption, clinicians need to become more cognizant of [....] » Read More

Smita D More, Speaker at Drug Delivery Conferences 2022
Oral Presentation
Smita D More, Savitribai Phule Pune University, India

One of the novel advanced techniques established for enhancement of the dissolution rate and bioavailability, controlling or modifying drug release, taste masking, and stabilizing the active pharmaceutical ingredient (API) is Hot melt extrusion (HME).  A combination of Drugs [....] » Read More

Yaffa Machnes, Speaker at Drug Delivery Conferences
Oral Presentation
Yaffa Machnes, Bar-Ilan University, Israel

The prices of patented pharmaceutical drugs like Afifon became a public concern and politicians all over the world discussed this matter. These prices are causing concern to Health Funds whose budget did not increase according to the prices of drugs. We look at the strategy of Is [....] » Read More

Muhammad Zubair, Speaker at Pharmaceutical Conferences
Oral Presentation
Muhammad Zubair, Indus Pharma Pvt Ltd, Pakistan

The COVID-19 pandemic continues to be a big threat to the world, this pandemic has had a profound impact on the health, social, and economic situation of the world. One of the biggest challenges of this pandemic is to deal with the continuity of pharmaceutical manufacturing & [....] » Read More

Mazen, Speaker at Drug Delivery Conferences
Poster Presentation (Virtual)
Mazen, Armed forces hospitals, Saudi Arabia

While the treatments for the respiratory disease vary, the efficacy of drugs is frequently limited by their inability to reach the target site of action. One of the largest limitations underlying current treatment methodologies is the inability for therapeutics to discriminate be [....] » Read More

Shaimaa Mahmoud Abdelhalim, Speaker at Pharmaceutical Conferences
Poster Presentation
Shaimaa Mahmoud Abdelhalim, Fakeeh college of medical science, Saudi Arabia

Sickle Cell Anemia (SCA), also called Sickle Cell Disease (SCD), is an inherited hematological disorder characterized by a syndrome of acute anemia and a painful crisis. The sickling hemoglobin, Hgb-S caus- es viscosity and inflammation of blood vessels. Eventually, the red blood [....] » Read More